Evidence map›Paper›PMID 34853408›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2022

α1-Adrenergic receptor mediates adipose-derived stem cell sheet-induced protection against chronic heart failure after myocardial infarction in rats.

Hiromu Horie, Ichiro Hisatome, Yasutaka Kurata, Yasutaka Yamamoto, Tomomi Notsu, Maaya Adachi, Peili Li, Masanari Kuwabara, Takuki Sakaguchi, Yoshiharu Kinugasa and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 1 country.

Hiromu HorieDivision of Cardiovascular Surgery, Department of Surgery, Tottori University Faculty of Medicine, Yonago, Japan.
Ichiro HisatomeDivision of Regenerative Medicine and Therapeutics, Tottori University Graduate School of Medical Science, Yonago, Japan.
Yasutaka KurataDepartment of Physiology II, Kanazawa Medical University, Uchinada, Japan. yasu@kanazawa-med.ac.jp.
Yasutaka YamamotoDivision of Regenerative Medicine and Therapeutics, Tottori University Graduate School of Medical Science, Yonago, Japan.
Tomomi NotsuDivision of Regenerative Medicine and Therapeutics, Tottori University Graduate School of Medical Science, Yonago, Japan.
Maaya AdachiDivision of Regenerative Medicine and Therapeutics, Tottori University Graduate School of Medical Science, Yonago, Japan.
Peili LiDivision of Regenerative Medicine and Therapeutics, Tottori University Graduate School of Medical Science, Yonago, Japan.
Masanari KuwabaraIntensive Care Unit and Department of Cardiology, Toranomon Hospital, Tokyo, Japan.
Takuki SakaguchiDivision of Medical Education, Department of Medical Education, Tottori University Faculty of Medicine, Yonago, Japan.
Yoshiharu KinugasaDivision of Cardiovascular Medicine, Department of Molecular Medicine and Therapeutics, Faculty of Medicine, Tottori University, Yonago, Japan.
Junichiro MiakeDepartment of Pharmacology, Tottori University Faculty of Medicine, Yonago, Japan.
Satoshi KobaDivision of Integrative Physiology, Faculty of Medicine, Tottori University, Yonago, Japan.
Motokazu TsunetoDivision of Regenerative Medicine and Therapeutics, Tottori University Graduate School of Medical Science, Yonago, Japan.
Yasuaki ShirayoshiDivision of Regenerative Medicine and Therapeutics, Tottori University Graduate School of Medical Science, Yonago, Japan.
Haruaki NinomiyaDepartment of Biological Regulation, Tottori University Faculty of Medicine, Yonago, Japan.
Shin ItoDepartment of Clinical Research and Development, National Cerebral and Cardiovascular Center, Suita, Japan.
Masafumi KitakazeHanwa Daini Senboku Hospital, Sakai, Osaka, Japan.
Kazuhiro YamamotoDivision of Cardiovascular Medicine, Department of Molecular Medicine and Therapeutics, Faculty of Medicine, Tottori University, Yonago, Japan.
Yasushi YoshikawaDivision of Cardiovascular Surgery, Department of Surgery, Tottori University Faculty of Medicine, Yonago, Japan.
Motonobu NishimuraDivision of Cardiovascular Surgery, Department of Surgery, Tottori University Faculty of Medicine, Yonago, Japan.
Tottori University · JPKanazawa Medical University · JPNational Cerebral and Cardiovascular Center · JPToranomon Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell-based therapy using adipose-derived stem cells (ADSCs) has emerged as a novel therapeutic approach to treat heart failure after myocardial infarction (MI). The purpose of this study was to determine whether inhibition of α1-adrenergic receptors (α1-ARs) in ADSCs attenuates ADSC sheet-induced improvements in cardiac functions and inhibition of remodeling after MI. ADSCs were isolated from fat tissues of Lewis rats. In in vitro studies using cultured ADSCs, we determined the mRNA levels of vascular endothelial growth factor (VEGF)-A and α1-AR under normoxia or hypoxia and the effects of norepinephrine and an α1-blocker, doxazosin, on the mRNA levels of angiogenic factors. Hypoxia increased α1-AR and VEGF mRNA levels in ADSCs. Norepinephrine further increased VEGF mRNA expression under hypoxia; this effect was abolished by doxazosin. Tube formation of human umbilical vein endothelial cells was promoted by conditioned media of ADSCs treated with the α1 stimulant phenylephrine under hypoxia but not by those of ADSCs pretreated with phenylephrine plus doxazosin. In in vivo studies using rats with MI, transplanted ADSC sheets improved cardiac functions, facilitated neovascularization, and suppressed fibrosis after MI. These effects were abolished by doxazosin treatment. Pathway analysis from RNA sequencing data predicted significant upregulation of α1-AR mRNA expression in transplanted ADSC sheets and the involvement of α1-ARs in angiogenesis through VEGF. In conclusion, doxazosin abolished the beneficial effects of ADSC sheets on rat MI hearts as well as the enhancing effect of norepinephrine on VEGF expression in ADSCs, indicating that ADSC sheets promote angiogenesis and prevent cardiac dysfunction and remodeling after MI via their α1-ARs.

Indexed as

Heart FailureMyocardial InfarctionReceptors, Adrenergic, alpha-1AnimalsHumansHuman Umbilical Vein Endothelial CellsNeovascularization, PhysiologicRatsRats, Inbred LewStem CellsVascular Endothelial Growth Factor AReceptors, Adrenergic, alpha-1Vascular Endothelial Growth Factor AAdipose-derived stem cellCell sheetDoxazosinRNA sequencing analysisα1 Adrenergic receptor

Identifiers

PMID34853408
OpenAlexW3216436600

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.